Transmedics Group Inc is a biotechnology company focused on revolutionizing the organ transplant process through innovative medical technologies
They have developed a unique organ preservation and transportation system that optimizes the viability of donor organs, specifically targeting hearts, lungs, and livers. By employing advanced perfusion technology, Transmedics aims to improve patient outcomes and increase the availability of transplantable organs, ultimately addressing the critical shortages faced in the transplant community. Their commitment to enhancing the transplant experience positions them as a leader in the field of organ transplantation.
NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating TransMedics Group, Inc. (“TransMedics”) (NASDAQTMDX) for potential violations of the federal securities laws.
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Quanterix Corporation (NASDAQQTRX) and TransMedics Group, Inc. NASDAQ:TMDXNASDAQTMDX)
NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX) on behalf of TransMedics stockholders. Our investigation concerns whether TransMedics has violated the federal securities laws and/or engaged in other unlawful business practices.
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of TransMedics Group, Inc. (NASDAQTMDX) (“TransMedics”).
RADNOR, PA - January 15, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of TransMedics Group, Inc. (NASDAQTMDX) (“TransMedics”).
NEW YORK - January 15, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TransMedics Group, Inc. (“TransMedics” or “the Company”) (NASDAQTMDX) for violations of the securities laws.
NEW YORK - January 14, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMedics Group, Inc. (NASDAQTMDX) resulting from allegations that TransMedics may have issued materially misleading business information to the investing public.
TransMedics faces allegations from Scorpion Capital of fraud and organ trafficking, while the company rebuffs the claims as baseless market manipulation.
NEW YORK - January 13, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).
